Elise Sverre Cand. Med.

Prosjekt: Socio-demographic, medical and psychosocial factors associated with unfavourable risk factor control after coronary events.

Medisinsk avdeling Drammen sykehus med akademisk tilknytning til Avdeling for medisinsk atferdsvitenskap, UiO. Hovedveileder: John Munkhaugen, biveiledere: Toril, Dammen, Jan Erik Otterstad, Einar Husebye.

Disputas: Elise Sverre – Institutt for medisinske basalfag

Kari Peersen Can. San.

Prosjekt: Cardiac rehabilitation, physical activity and risk factor control after coronary events.

Hjerteavdelingen, Sykehuset i Vestfold, akademisk tilknyttet Institutt for klinisk medisin, UiO. Hovedveileder: Jan Erik Otterstad, biveiledere: John Munkhaugen, Lars Gullestad, Toril Dammen

Public Defence: Kari Peersen – Institute of Clinical Medicine

Oscar Kristiansen Cand. Med.

Prosjekt: Personalized statin treatment in coronary prevention based on direct drug monitoring.

Medisinsk avdeling Drammen Sykehus, akademisk tilknytning til Avdeling for medisinsk atferdsvitenskap. Hovedveileder: John Munkhaugen, biveiledere: Nils Tore Vethe, Einar Husebye, Toril Dammen.

Public Defence: Oscar Kristiansen – Institute of Basic Medical Sciences

Kristin Torgersen Cand. Med.

Prosjekt: Type D personality in coronary heart disease (CHD) patients: CHD risk, genetic pleiotropy and prognosis.

Avdeling for atferdsmedisin, UiO. Hovedveileder: Toril Dammen. Biveiledere: John Munkhaugen, Srdjan Djurovic, Ole A Andreassen.

Public Defence: Kristin Stensland Torgersen – Institute of Basic Medical Sciences

Lars Aastebøl Frøjd, Cand. Med.

Prosjekt: Insomnia in patients with coronary heart disease: A cross-sectional and prospective observational study

Klinikk psykisk helse og avhengighet, Forsknings- og innovasjonsavdelingen, Seksjon for behandlingsforskning, Oslo universitetssykehus. Avdeling for medisinsk atferdsvitenskap, UiO. Hovedveileder: Toril, Dammen. Biveiledere: John Munkhaugen, Costas Papageoriou, Inger Hilde Nordhus.

Public defence: Lars Aastebøl Frøjd – Institute of Clinical Medicine

Trine Lauritzen, MD.

Prosjekt: New pathophysiological knowledge and diagnostic biomarkers for atorvastatindependent muscle side effects in patients with coronary heart disease.

Institutt for klinisk medisin ved UiO. Hovedveileder: Nils Tore Vethe (UiO, OUS HF). Biveiledere: John Munkhaugen (VVHF – DS, UiO, NTNU), Stein Bergan (OUS HF), Lars Gullestad. (UiO, OUS HF).

Public defence: Trine Lauritzen – Institute of Clinical Medicine

Doktoravhandling 2025: New pathophysiological knowledge and diagnostic biomarkers for atorvastatin-dependent muscle side effects in patients with coronary heart disease – Nasjonalt vitenarkiv

Jonas Pivoriunas, MD.

Prosjekt: Evaluation of a novel blood test to monitor statin treatment in cardiovascular disease prevention

Institutt for klinisk medisin ved UiO. Hovedveileder: Elise Sverre (VVHF – DS). Biveiledere: John Munkhaugen (VVHF – DS, UiO, NTNU), Nils Tore Vethe (UiO, OUS HF) og Toril Dammen (OUS HF).

Public Defence: Jonas Pivoriunas – Institute of Basic Medical Sciences

Doktoravhandling 2025: Evaluation of a novel blood test to monitor statin treatment in cardiovascular disease prevention – Nasjonalt vitenarkiv

Ingrid Engebretsen, Msc.

Prosjekt: Treatment patterns and adherence to lipid lowering drugs in Norway

Institutt for klinisk medisin ved UiO. Hovedveileder: Professor John Munkhaugen (VVHF – DS, UiO, NTNU). Biveiledere: Kristoffer Bugge (UiO, Oslo Economics) , Henrik Støvring (Oslo Economics, Syddansk Universitet, Steno Diabetes Center, Aarhus Universitetet), Sigrun Halvorsen (UiO, OUS).

Public Defence: Ingrid Engebretsen – Institute of Basic Medical Sciences

Karin Pleym, Msc

Prosjekt: Smoking cessation after a cardiovascular disease event – two interdisciplinary, randomized clinical studies

Avdeling for medisinsk atferdsvitenskap, UiO. Hovedveileder: John Munkhaugen (VVHF – DS, UiO, NTNU). Biveiledere: Toril Dammen (OUS HF), Elise Sverre (VVHF – DS, UiO, NTNU), Serena Tonstad (OUS)

Public Defence: Karin Pleym – Institute of Basic Medical Sciences

Doktoravhandling 2026: Clinical and health economic effects of an in-hospital nurse-led smoking cessation intervention after atherosclerotic vascular disease – Nasjonalt vitenarkiv